Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Shlien

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Cancer Research|October 11, 2023
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT CarcinomaR Taylor Durall, Julianna Huang, Luke Wojenski, et al.
NPJ Genomic Medicine|July 2, 2025
Assessing the diagnostic impact of blood transcriptome profiling in a pediatric cohort previously assessed by genome sequencingHuayun Hou, Kyoko E Yuki, Gregory Costain, et al.
Nature Medicine|July 17, 2025
Clinical utility of targeted RNA sequencing in cancer molecular diagnosticsRobert Siddaway, Aida I Glembocki, Anthony Arnoldo, et al.
Nature Communications|November 12, 2024
Inter-chromosomal contacts demarcate genome topology along a spatial gradientMilad Mokhtaridoost, Jordan J Chalmers, Marzieh Soleimanpoor, et al.
Genome Medicine|April 20, 2017
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenZachary R Chalmers, Caitlin F Connelly, David Fabrizio, et al.
Cancer Research Communications|June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni SyndromeVallijah Subasri, Nicholas Light, Nisha Kanwar, et al.
Nature|June 15, 2022
Signatures of copy number alterations in human cancerChristopher D Steele, Ammal Abbasi, S M Ashiqul Islam, et al.
JCO Precision Oncology|June 7, 2021
Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With RhabdomyosarcomaJung Kim, Nicholas Light, Vallijah Subasri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroupsDiana M Merino, Adam Shlien, Anita Villani, et al.
Nature Communications|January 5, 2023
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosisNicholas Light, Mehdi Layeghifard, Ayush Attery, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Cancer Research|October 11, 2023
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT CarcinomaR Taylor Durall, Julianna Huang, Luke Wojenski, et al.
NPJ Genomic Medicine|July 2, 2025
Assessing the diagnostic impact of blood transcriptome profiling in a pediatric cohort previously assessed by genome sequencingHuayun Hou, Kyoko E Yuki, Gregory Costain, et al.
Nature Medicine|July 17, 2025
Clinical utility of targeted RNA sequencing in cancer molecular diagnosticsRobert Siddaway, Aida I Glembocki, Anthony Arnoldo, et al.
Nature Communications|November 12, 2024
Inter-chromosomal contacts demarcate genome topology along a spatial gradientMilad Mokhtaridoost, Jordan J Chalmers, Marzieh Soleimanpoor, et al.
Genome Medicine|April 20, 2017
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenZachary R Chalmers, Caitlin F Connelly, David Fabrizio, et al.
Cancer Research Communications|June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni SyndromeVallijah Subasri, Nicholas Light, Nisha Kanwar, et al.
Nature|June 15, 2022
Signatures of copy number alterations in human cancerChristopher D Steele, Ammal Abbasi, S M Ashiqul Islam, et al.
JCO Precision Oncology|June 7, 2021
Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With RhabdomyosarcomaJung Kim, Nicholas Light, Vallijah Subasri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroupsDiana M Merino, Adam Shlien, Anita Villani, et al.
Nature Communications|January 5, 2023
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosisNicholas Light, Mehdi Layeghifard, Ayush Attery, et al.
Pageof 11